. . . . . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en xineru de 1993"@ast . . . . . . . "Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways?"@nl . . . . . . . . . . . . "Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)"@sq . "Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)"@en . . . "Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)"@sq . "1993-01-01T00:00:00Z"^^ . . "Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)"@en . . . "1" . . . . . . . . . . . . . . . . . . . "M L Carlsson" . . "7907483" . . . . . . . . "94" . . . . . . . . . "Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways?"@nl . . . . "Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)"@sq . . "wetenschappelijk artikel"@nl . . . . "scientific article published on 01 January 1993"@en . . . . . . . . "Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways?"@nl . "Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)"@en . . "Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)"@en . "artikull shkencor i botuar m\u00EB 01 janar 1993"@sq . "1-10" . . "10.1007/BF01244978" . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0441\u0456\u0447\u043D\u0456 1993"@uk . . . . . . . . .